GlassScriptPhysician profile
John Todd Louis
NPI 1679549570
$1,621.34
in general payments reported to CMS, 2019-2025
20 companies · $438 in 2025
The $438 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2020: $244 · 2021: $56.80 · 2022: $16.66 · 2023: $285 · 2024: $329 · 2025: $438.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,052.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,051.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $305.41 | 2024-2025 | Bimzelx |
| Melinta Therapeutics, LLC | $231.64 | 2019 | |
| Incyte Corporation | $195.89 | 2023-2025 | Opzelura |
| Sun Pharmaceutical Industries INC. | $126.97 | 2024-2025 | |
| Lilly USA, LLC | $102.47 | 2023-2024 | Olumiant, Taltz |
| Sientra, INC. | $93.72 | 2020 | |
| Janssen Biotech, INC. | $84.18 | 2023-2025 | Tremfya |
| Organogenesis INC. | $67.92 | 2023 | Puraply |
| Intuitive Surgical, INC. | $66.21 | 2020 | |
| Davol INC. | $51.85 | 2021-2025 | Galaflex Lite |
| Mentor Worldwide LLC | $50.35 | 2020-2022 | |
| Rayner Intraocular Lenses Limited | $40.86 | 2025 | Omidria |
| Novartis Pharmaceuticals Corporation | $33.22 | 2023 | |
| Allergan, INC. | $31.79 | 2019-2020 | |
| Kci USA, INC. | $28.46 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $26.16 | 2020 | |
| Leo Pharma INC. | $24.55 | 2023 | Adbry |
| Ani Pharmaceuticals, INC. | $22.03 | 2024 | Purified Cortrophin Gel |
| Abbvie INC. | $21.68 | 2021 | |
| Helsinn Therapeutics (U.S.), INC. | $15.98 | 2023 | Valchlor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Louis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.